Last reviewed · How we verify
NCT05153278
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
trial testing Packed red blood cells in Iron Deficiency Anemia Treatment in 130 participants. Completed in 26 August 2020.
26 August 2020
Quick facts
| Lead sponsor | Texas Tech University Health Sciences Center, El Paso |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 26 October 2018 |
| Primary completion | 26 August 2020 |
| Estimated completion | 26 August 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Packed red blood cells — full drug profile →
- Intravenous drug — full drug profile →
Conditions studied
- Iron Deficiency Anemia Treatment — all drugs for Iron Deficiency Anemia Treatment →
- Iron-deficiency — all drugs for Iron-deficiency →
- Iron Deficiency Anemia Due to Blood Loss — all drugs for Iron Deficiency Anemia Due to Blood Loss →
- Iron Deficiency Anemia — all drugs for Iron Deficiency Anemia →
Sponsor
Texas Tech University Health Sciences Center, El Paso
Who can join
Adults 18 to 80, any sex, with Iron Deficiency Anemia Treatment or Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will retrospectively collect data of patients infused at UMC's emergency department (ED) with long acting irons (ferric carboxymaltose, iron dextran, iron sucrose, etc.), in addition, patients infused with blood products, with intent to treat iron deficiency anemia (IDA). Patient records reviewed will be from patients who were infused at UMC ED from January 2013 to June 2018. Primary aim of analysis will be to investigate superiority between interventions implemented for treating IDA. In addition, the investigators will utilize data to characterize patients who used ED services as an avenue to receive treatment for IDA. Further, the investigators will conduct cost analysis between different IDA directed treatments administered in the ED at UMC.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05153278
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Iron Deficiency Anemia Treatment
Currently open trials in the same condition.
- NCT07014371 — Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA) · NA · recruiting
- NCT06637137 — Patient Blood Management in Patients Scheduled for Cardiac Surgery · recruiting
Other Texas Tech University Health Sciences Center, El Paso trials
Trials by the same sponsor.
- NCT06016465 — Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? · EARLY_PHASE1 · recruiting
- NCT05303116 — Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms? · completed
- NCT05174988 — Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles · NA · completed
- NCT05077917 — Cromolyn Sodium for Treatment of COVID-19 Pneumonia · Phase 3 · terminated
- NCT04786379 — Surgical Management of Knee Septic Arthritis · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05153278 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Tech University Health Sciences Center, El Paso
- Last refreshed: 24 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05153278.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing